Documentation
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria
Last updated: 2023-02-03 03:36
Integreo 16: Dinant/Beauraing Geïntegreerde zorg chronische ziekten
Last updated: 2023-02-03 03:36